Aurobindo Pharma Investor Relations Material
Latest events
Q1 24/25
Aurobindo Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Aurobindo Pharma Limited
Access all reports
Aurobindo Pharma Limited is an Indian pharmaceutical company engaged in the research, development, manufacturing, and marketing of a wide range of generic medicines. The company’s product portfolio includes antibiotics, antiretrovirals, cardiovascular drugs, central nervous system agents, gastroenterology products, and anti-allergics, among others. Aurobindo Pharma serves markets globally, supplying generic pharmaceuticals to hospitals, pharmacies, and healthcare providers. The company also produces active pharmaceutical ingredients (APIs) and has expanded into specialty drugs and biosimilars. The company is headquartered in Hyderabad, India, and its shares are listed on the NSE.
Key slides for Aurobindo Pharma Limited
Q2 24/25
Aurobindo Pharma Limited
Q2 24/25
Aurobindo Pharma Limited
Latest articles
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
AUROPHARMA
Country
🇮🇳 India